Aspen Wealth Strategies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$288K Buy
10,261
+41
+0.4% +$1.09K 0.15% 76
2025
Q4
$254K Buy
10,220
+100
+1% +$2.52K 0.14% 77
2025
Q3
$258K Buy
10,120
+137
+1% +$3.38K 0.14% 79
2025
Q2
$242K Buy
9,983
+841
+9% +$19.6K 0.15% 78
2025
Q1
$232K Buy
9,142
+353
+4% +$9.24K 0.15% 78
2024
Q4
$233K Sell
8,789
-1,418
-14% -$38.5K 0.15% 76
2024
Q3
$295K Buy
10,207
+1,843
+22% +$53.8K 0.19% 68
2024
Q2
$251K Buy
8,364
+287
+4% +$7.9K 0.17% 67
2024
Q1
$224K Hold
8,077
0.15% 74
2023
Q4
$233K Buy
8,077
+91
+1% +$2.75K 0.17% 74
2023
Q3
$265K Buy
7,986
+200
+3% +$7.07K 0.21% 59
2023
Q2
$286K Sell
7,786
-5,233
-40% -$204K 0.22% 57
2023
Q1
$531K Buy
13,019
+994
+8% +$42.9K 0.41% 31
2022
Q4
$616K Buy
+12,025
New +$577K 0.49% 28

Other funds holding PFE

Aspen Wealth Strategies's PFE Position: Q1 2026 in Review

Aspen Wealth Strategies increased its Pfizer (PFE) stake by 0.4% in Q1 2026, buying an estimated $1.09K and bringing the position to 10,261 shares worth $288K. The position accounts for 0.15% of the portfolio, ranked #76.

Aspen Wealth Strategies first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $616K in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Aspen Wealth Strategies held 10,261 shares of Pfizer worth $288K as of Q1 2026.
  • Aspen Wealth Strategies bought 41 Pfizer shares in Q1 2026, an estimated $1.09K.
  • Pfizer made up 0.15% of Aspen Wealth Strategies's portfolio in Q1 2026, its #76 holding.
  • Aspen Wealth Strategies first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Aspen Wealth Strategies's Pfizer position peaked at $616K in Q4 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Aspen Wealth Strategies's 13F filing for Q1 2026, filed 8 May 2026.